These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2411962

  • 21. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 22. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J, Jávor A.
    Orv Hetil; 1993 Jul 11; 134(28):1529-32. PubMed ID: 7688112
    [Abstract] [Full Text] [Related]

  • 23. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct 11; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
    Wang TY, Kawaguchi TP.
    Ann Clin Lab Sci; 1986 Oct 11; 16(6):461-6. PubMed ID: 3800301
    [Abstract] [Full Text] [Related]

  • 26. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T, Kumamoto Y, Yamazaki K, Umehara T, Miyao N, Ohmura K, Iwazawa M.
    Hinyokika Kiyo; 1988 Jun 11; 34(6):987-95. PubMed ID: 2464917
    [Abstract] [Full Text] [Related]

  • 27. Prostate specific antigen. Experimental and clinical observations.
    Huber PR, Schnell Y, Hering F, Rutishauser G.
    Scand J Urol Nephrol Suppl; 1987 Jun 11; 104():33-9. PubMed ID: 2449722
    [Abstract] [Full Text] [Related]

  • 28. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V, De Bellis G, Prezioso D, Sanseverino R, Iannucci F, Padulano P.
    Minerva Med; 1986 Mar 31; 77(13):503-4. PubMed ID: 2422605
    [No Abstract] [Full Text] [Related]

  • 29. [Prostate-specific antigen (PSA): diagnostic and prognostic implications in the evaluation of carcinoma of the prostate].
    Lo Cigno M, Montanari F, Bercovich E, Soli M, Emili E, Dal Pozzo C, Platè L, Bianchi D.
    Arch Ital Urol Nefrol Androl; 1989 Mar 31; 61(1):29-36. PubMed ID: 2469127
    [Abstract] [Full Text] [Related]

  • 30. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J, de Torres Mateos JA, Soler-Roselló A.
    Actas Urol Esp; 1988 Mar 31; 12(2):152-7. PubMed ID: 2458015
    [No Abstract] [Full Text] [Related]

  • 31. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
    Killian CS, Emrich LJ, Vargas FP, Yang N, Wang MC, Priore RL, Murphy GP, Chu TM.
    J Natl Cancer Inst; 1986 Feb 31; 76(2):179-85. PubMed ID: 2418245
    [Abstract] [Full Text] [Related]

  • 32. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
    Fuse H, Akimoto S, Shimazaki J.
    Hinyokika Kiyo; 1986 Dec 31; 32(12):1813-9. PubMed ID: 2435130
    [Abstract] [Full Text] [Related]

  • 33. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.
    Kuriyama M, Wang MC, Papsidero LD, Killian CS, Shimano T, Valenzuela L, Nishiura T, Murphy GP, Chu TM.
    Cancer Res; 1980 Dec 31; 40(12):4658-62. PubMed ID: 6159971
    [Abstract] [Full Text] [Related]

  • 34. [Usefulness of free prostate specific antigen in the detection of prostate cancer].
    Azócar G, Castillo O, Van Cauwelaert R, Cumsille MA, Campero JM, Aguirre C, Wöhler C.
    Rev Med Chil; 1999 Feb 31; 127(2):151-7. PubMed ID: 10436694
    [Abstract] [Full Text] [Related]

  • 35. Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.
    Killian CS, Yang N, Emrich LJ, Vargas FP, Kuriyama M, Wang MC, Slack NH, Papsidero LD, Murphy GP, Chu TM.
    Cancer Res; 1985 Feb 31; 45(2):886-91. PubMed ID: 2578313
    [Abstract] [Full Text] [Related]

  • 36. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L, Géraud M, Dugué MA.
    Ann Urol (Paris); 1988 Feb 31; 22(3):206-10. PubMed ID: 2456714
    [Abstract] [Full Text] [Related]

  • 37. [Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer].
    Meguro N, Maeda O, Saiki S, Kinouchi T, Kuroda M, Usami M, Kotake T.
    Hinyokika Kiyo; 1998 Sep 31; 44(9):639-43. PubMed ID: 9805668
    [Abstract] [Full Text] [Related]

  • 38. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y, Yoshki T, Okada K, Yoshida O, Yamamoto N, Sakatoku J, Sugimura Y, Kawamura J.
    Hinyokika Kiyo; 1989 Sep 31; 35(9):1519-28. PubMed ID: 2479237
    [Abstract] [Full Text] [Related]

  • 39. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan 31; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.